Literature DB >> 19699773

Safety assessment of black cumin fixed and essential oil in normal Sprague Dawley rats: Serological and hematological indices.

M Tauseef Sultan1, Masood Sadiq Butt, Faqir Muhammad Anjum.   

Abstract

Black cumin (Nigella sativa L.) is unique in its nutritional profile and it's fixed and essential oils are phytochemicals rich fractions. However, safety assessment is required before recommending their use. This study was designed to evaluate the safety of black cumin fixed oil (BCFO) and black cumin essential oil (BCEO) through animal modeling using Sprague dawley rats as test animals. The results indicated that BCFO @ 4.0% and BCEO @ 0.30% are safe as serological indices like liver and kidney functioning tests, serum protein profile, level of cardiac enzymes, electrolytes balance were remained in the normal ranges even after 56days of study. Similarly, indices of red and white blood cells remained within the defined limits. Moreover, diets were insignificant in their impression regarding organs to body weight ratio. However, group of rats fed on BCFO gained less weight as compared to control that shows slight anorexic effect of BCFO which can be useful in obesity related disorders. In the nutshell, presence of phytochemicals in black cumin fixed and essential oils as well as their safe status can positively be used against lifestyle disorders.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19699773     DOI: 10.1016/j.fct.2009.08.011

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  8 in total

1.  Effect of Nigella Sativa oil versus metformin on glycemic control and biochemical parameters of newly diagnosed type 2 diabetes mellitus patients.

Authors:  Hebatallah Ahmed Mohamed Moustafa; Lamia Mohamed El Wakeel; Mohamed Reda Halawa; Nagwa Ali Sabri; Alshaymaa Zaki El-Bahy; Abdel Nasser Singab
Journal:  Endocrine       Date:  2019-05-31       Impact factor: 3.633

Review 2.  North African Medicinal Plants Traditionally Used in Cancer Therapy.

Authors:  Jorge M Alves-Silva; Abderrahmane Romane; Thomas Efferth; Lígia Salgueiro
Journal:  Front Pharmacol       Date:  2017-06-26       Impact factor: 5.810

Review 3.  Natural therapeutic approach of Nigella sativa (Black seed) fixed oil in management of Sinusitis.

Authors:  Mohaddese Mahboubi
Journal:  Integr Med Res       Date:  2018-02-02

4.  Cardiac Inotropic Effect of Long-Term Administration of Oral Thymoquinone.

Authors:  Lubna Ibrahim Al Asoom; Mohammad Taha Al-Hariri
Journal:  Evid Based Complement Alternat Med       Date:  2019-06-25       Impact factor: 2.629

5.  Nigella sativa fixed and essential oil modulates glutathione redox enzymes in potassium bromate induced oxidative stress.

Authors:  Muhammad Tauseef Sultan; Masood Sadiq Butt; Roselina Karim; Waqas Ahmed; Ubedullah Kaka; Shakeel Ahmad; Saikat Dewanjee; Hawa Z E Jaafar; M Zia-Ul-Haq
Journal:  BMC Complement Altern Med       Date:  2015-09-18       Impact factor: 3.659

6.  Antihyperglycemic effect of thymoquinone and oleuropein, on streptozotocin-induced diabetes mellitus in experimental animals.

Authors:  Sibghatullah Muhammad Ali Sangi; Mansour Ibrahim Sulaiman; Mohammed Fawzy Abd El-Wahab; Elsamoual Ibrahim Ahmedani; Soad Shaker Ali
Journal:  Pharmacogn Mag       Date:  2015-10       Impact factor: 1.085

7.  Nigella sativa Fixed and Essential Oil Supplementation Modulates Hyperglycemia and Allied Complications in Streptozotocin-Induced Diabetes Mellitus.

Authors:  Muhammad Tauseef Sultan; Masood Sadiq Butt; Roselina Karim; M Zia-Ul-Haq; Rizwana Batool; Shakeel Ahmad; Luigi Aliberti; Vincenzo De Feo
Journal:  Evid Based Complement Alternat Med       Date:  2014-01-08       Impact factor: 2.629

8.  Effect of Nigella sativa fixed and essential oils on antioxidant status, hepatic enzymes, and immunity in streptozotocin induced diabetes mellitus.

Authors:  Muhammad Tauseef Sultan; Masood Sadiq Butt; Roselina Karim; Shahzad Zafar Iqbal; Shakeel Ahmad; Muhammad Zia-Ul-Haq; Luigi Aliberti; Atif Nisar Ahmad; Vincenzo De Feo
Journal:  BMC Complement Altern Med       Date:  2014-06-17       Impact factor: 3.659

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.